{"title":"AI Applications in Transfusion Medicine: Opportunities, Challenges, and Future Directions.","authors":"Merav Barzilai, Omri Cohen","doi":"10.1159/000546303","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial intelligence (AI) is reshaping healthcare, with its applications in transfusion medicine showing great promise to address longstanding challenges. This review explores the integration of AI-driven tools, including Machine Learning (ML), Deep Learning, Natural Language Processing (NLP), and predictive analytics, across various domains of transfusion medicine. From enhancing donor management and optimizing blood product quality to predicting transfusion needs and assessing bleeding risks, AI has demonstrated its potential to improve operational efficiency, patient safety, and resource allocation. Additionally, AI-powered systems enable more accurate blood antigen phenotyping, automate hemovigilance workflows, and streamline inventory management through advanced forecasting models. While these advancements are largely exploratory, early studies highlight the growing importance of AI in improving patient outcomes and advancing precision medicine. However, challenges such as variability in clinical workflows, algorithmic transparency, equitable access, and ethical concerns around data privacy and bias must be addressed to ensure responsible integration. Future directions in this rapidly evolving field include refining AI models for scalability and exploring emerging areas such as federated learning and AI-driven clinical trials. By addressing these challenges, AI has the potential to redefine transfusion medicine, delivering safer, more efficient, and equitable practices worldwide.</p>","PeriodicalId":6981,"journal":{"name":"Acta Haematologica","volume":" ","pages":"1-20"},"PeriodicalIF":1.7000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Haematologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000546303","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Artificial intelligence (AI) is reshaping healthcare, with its applications in transfusion medicine showing great promise to address longstanding challenges. This review explores the integration of AI-driven tools, including Machine Learning (ML), Deep Learning, Natural Language Processing (NLP), and predictive analytics, across various domains of transfusion medicine. From enhancing donor management and optimizing blood product quality to predicting transfusion needs and assessing bleeding risks, AI has demonstrated its potential to improve operational efficiency, patient safety, and resource allocation. Additionally, AI-powered systems enable more accurate blood antigen phenotyping, automate hemovigilance workflows, and streamline inventory management through advanced forecasting models. While these advancements are largely exploratory, early studies highlight the growing importance of AI in improving patient outcomes and advancing precision medicine. However, challenges such as variability in clinical workflows, algorithmic transparency, equitable access, and ethical concerns around data privacy and bias must be addressed to ensure responsible integration. Future directions in this rapidly evolving field include refining AI models for scalability and exploring emerging areas such as federated learning and AI-driven clinical trials. By addressing these challenges, AI has the potential to redefine transfusion medicine, delivering safer, more efficient, and equitable practices worldwide.
期刊介绍:
''Acta Haematologica'' is a well-established and internationally recognized clinically-oriented journal featuring balanced, wide-ranging coverage of current hematology research. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis and differentiation is contained in first-rate basic and clinical papers some of which are accompanied by editorial comments by eminent experts. These are supplemented by short state-of-the-art communications, reviews and correspondence as well as occasional special issues devoted to ‘hot topics’ in hematology. These will keep the practicing hematologist well informed of the new developments in the field.